While no HER2 expression and highly over-expressive HER2 status tend to yield relatively clear results using these methods, biopsies of tumor tissue that have moderate expression can create challenges in accurately diagnosing HER2 quantity. The gene discussed is ERBB2; the disease is neoplasm.